Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome.
about
Overlapping irritable bowel syndrome and inflammatory bowel disease: less to this than meets the eye?Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disordersReview article: inhibition of methanogenic archaea by statins as a targeted management strategy for constipation and related disordersReduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome.Molecular analysis of the human faecal archaea in a southern Indian population.Altered gut microbiome in a mouse model of Gulf War Illness causes neuroinflammation and intestinal injury via leaky gut and TLR4 activation.Anti-nociceptive effect of Faecalibacterium prausnitzii in non-inflammatory IBS-like models.Accelerated dysbiosis of gut microbiota during aggravation of DSS-induced colitis by a butyrate-producing bacteriumThe microbiome of the oral mucosa in irritable bowel syndrome.Therapeutic Modulation of Gut Microbiota in Functional Bowel Disorders.Fermented milk containing Lactobacillus paracasei subsp. paracasei CNCM I-1518 reduces bacterial translocation in rats treated with carbon tetrachloride.Advantages of phylogenetic distance based constrained ordination analyses for the examination of microbial communities.Hydrogen sulphide as a signalling molecule regulating physiopathological processes in gastrointestinal motility.Genomics and metagenomics of trimethylamine-utilizing Archaea in the human gut microbiome.Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome.Irritable bowel syndrome: a gut microbiota-related disorder?Butyric acid - a well-known molecule revisited.A microbial signature for Crohn's disease.Stool consistency is significantly associated with pain perception.Unveiling the gut microbiota composition and functionality associated with constipation through metagenomic analyses.Intestinal microbiome-gut-brain axis and irritable bowel syndrome.Assessment of Anti-vinculin and Anti-cytolethal Distending Toxin B Antibodies in Subtypes of Irritable Bowel Syndrome.A Review of Microbiota and Irritable Bowel Syndrome: Future in Therapies.Characteristics of the bacterial microbiome in association with common intestinal parasites in irritable bowel syndrome.Saturated long-chain fatty acid-producing bacteria contribute to enhanced colonic motility in rats.Role of Gut Microbiota-Gut Hormone Axis in the Pathophysiology of Functional Gastrointestinal Disorders.Gut microbiota associations with common diseases and prescription medications in a population-based cohortEffect of probiotic Bifidobacterium bifidum G9-1 on the relationship between gut microbiota profile and stress sensitivity in maternally separated ratsThe Association Between Constipation or Stool Consistency and Pain Severity in Patients With Chronic Pain
P2860
Q26765219-FDAF11C0-ADF0-4B9A-8D1E-59A8F1D90A6DQ26777279-49B4762F-567A-495B-B8B9-C7CDA74DF289Q28084971-6FC4C435-9B10-4042-A953-2C0F848207E9Q36060516-BE2CB311-A713-4E7D-822B-9FCCE6D60CFBQ36288093-8817C37E-3E41-4683-9432-BA2D2812C945Q36318355-E150AE35-5664-4C3A-B7BF-7A906FE67044Q36500198-55E1682B-C4BC-4A93-AB60-B9D80D99AB46Q36970731-9F843743-0E04-4034-9173-5927AC6D197DQ37183296-3BDE50B3-8482-4822-83B2-AFD821CA8085Q37564122-4B92ADEF-5AD0-45DA-B188-393B69ED575AQ37734650-AC533494-3538-4843-96FC-38D09CA7BE23Q38661545-906BF5EC-D155-4825-80F6-CF81F0564220Q38717958-4CD4BB81-319C-4D7B-8C1E-2E95FBA171F6Q38741089-BDED040D-0E92-40E7-BECC-B8EC192CBD04Q38962543-633106EE-9C7D-4FCA-8B8E-1C7E629658DCQ39018403-E33EABBA-70EC-4B9F-8A1D-B5643E9FC7C5Q39431579-1C264533-DE43-4E11-AA57-2D552DFF8D4EQ41151351-1E055465-5F49-4D40-8447-5CD5622C8E4FQ41326438-302DEEAF-5A19-4E07-A591-C573391D1FC9Q41549187-358170FD-33EA-4B87-8E6E-F52F3249A6DAQ47773748-4236BACF-3491-40C3-9C76-1B9349018924Q51030537-185CF615-91D0-4974-A2D0-D2EFE776661EQ54263480-7C9947FF-3865-4912-BDE4-EEBC7CB4E5D5Q55395106-99A124FC-3739-458D-AAFE-E101F5D27BADQ55439068-C3E1BBD8-2A41-43DE-96A2-C30B39FAE555Q55527145-B2D2E477-A93F-4AB8-9327-15EC20F787F5Q57176780-86BB6C68-17F8-466A-BD28-F0EC8543BB5AQ58770780-21BF8710-D0C4-4CF7-A87D-73B45BF53442Q58788193-E9FDCC50-B058-4321-8491-02296CFD3D97
P2860
Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome.
description
2015 nî lūn-bûn
@nan
2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Reduction of butyrate- and met ...... with Irritable Bowel Syndrome.
@ast
Reduction of butyrate- and met ...... with Irritable Bowel Syndrome.
@en
type
label
Reduction of butyrate- and met ...... with Irritable Bowel Syndrome.
@ast
Reduction of butyrate- and met ...... with Irritable Bowel Syndrome.
@en
prefLabel
Reduction of butyrate- and met ...... with Irritable Bowel Syndrome.
@ast
Reduction of butyrate- and met ...... with Irritable Bowel Syndrome.
@en
P2093
P2860
P50
P356
P1433
P1476
Reduction of butyrate- and met ...... with Irritable Bowel Syndrome.
@en
P2093
Anna Accarino
Chaysavanh Manichanh
Francisco Guarner
Sara Mendez
Suchita Panda
P2860
P2888
P356
10.1038/SREP12693
P407
P577
2015-08-04T00:00:00Z
P5875
P6179
1034123084